Parkinson's Disease Trial, Recruiting NCT07642908 Sponsor: University of Michigan Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07642908
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 45 years of age or older, of any gender
  • People who have been diagnosed with Parkinson's disease based on a specific set of established diagnostic guidelines (known as the UK Parkinson's Disease Society Brain Bank Criteria)
  • People who have a specific gene change called an LRRK2 mutation, confirmed through a referral from the UM Movement Disorders clinic, a review of medical records, or previous participation in a study called PDGENEration

Who may not be able to join:

  • People who show signs of an atypical (unusual) form of parkinsonism rather than standard Parkinson's disease
  • People who have medical devices or conditions that make MRI scans unsafe, such as a pacemaker, aneurysm clips, metal in the eye, a cochlear implant, or severe claustrophobia
  • People whose MRI scan shows evidence of a large stroke or an abnormal growth in the brain
  • People who regularly take certain types of medications known as typical anticholinergic drugs or cholinesterase inhibitors (confirm with trial site)
  • People who have previously had deep brain stimulation surgery
  • People who are currently pregnant or breastfeeding
  • People who are experiencing thoughts of suicide, as identified by responses to a standard questionnaire (the Beck Depression Inventory)
  • People whose level of cognitive difficulty means they are unable to give informed consent, as assessed using a specific decision-making capacity tool
  • People who have any other condition that would make safe or meaningful participation in the study unsuitable (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Prabesh Kanel, PhD, University of Michigan

Phone: 734-998-6894

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
18 September 2025
Est. completion
17 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Cholinergic Differences Between leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease (PD) and Idiopathic/non-LRRK2 PD (iPD); Dopaminergic Differences Between LRRK2-PD and iPD; Association of Cholinergic Data With Cognition in LRRK2-PD; Association of Cholinergic Data With Postural Instability and Gait Difficulties (PIGD) in LRRK2-PD; Association of Dopaminergic Data With Cognition in LRRK2-PD; Association of Dopaminergic Data With PIGD in LRRK2-PD

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov